Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.810
-0.070 (-3.72%)
At close: Mar 25, 2025, 4:00 PM
1.840
+0.030 (1.66%)
After-hours: Mar 25, 2025, 6:10 PM EST
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 122 employees as of December 31, 2023. The number of employees decreased by 62 or -33.70% compared to the previous year.
Employees
122
Change (1Y)
-62
Growth (1Y)
-33.70%
Revenue / Employee
$1,785
Profits / Employee
-$879,132
Market Cap
66.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INO News
- 7 days ago - Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - PRNewsWire
- 12 days ago - INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19 - PRNewsWire
- 13 days ago - INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025 - PRNewsWire
- 5 weeks ago - Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript) - Seeking Alpha
- 5 weeks ago - Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications - PRNewsWire
- 6 weeks ago - Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference - PRNewsWire
- 7 weeks ago - INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire